Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease
Tanya Ralli, Yub Raj Neupane, Zoya Saifi, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 46, pp. 4677-4685
Closed Access | Times Cited: 11

Showing 11 citing articles:

Gut firmicutes: Relationship with dietary fiber and role in host homeostasis
Yonggan Sun, Shanshan Zhang, Qixing Nie, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 33, pp. 12073-12088
Closed Access | Times Cited: 164
Firmicutes
Yonggan Sun, Qixing Nie
Elsevier eBooks (2025), pp. 307-328
Closed Access
Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis
Jiezhong Chen, Luis Vitetta, Jeremy D. Henson, et al.
International Journal of Tryptophan Research (2022) Vol. 15
Open Access | Times Cited: 16
Deciphering the role of gut metabolites in non-alcoholic fatty liver disease
Tanya Ralli, Zoya Saifi, Neha Tyagi, et al.
Critical Reviews in Microbiology (2022) Vol. 49, Iss. 6, pp. 815-833
Closed Access | Times Cited: 12
Decoding the bidirectional relationship between gut microbiota and COVID-19
Tanya Ralli, Zoya Saifi, Anjali Rathee, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13801-e13801
Open Access | Times Cited: 7
Hovenia dulcis: a Chinese medicine that plays an essential role in alcohol-associated liver disease
Yi-Xiang He, Mengnan Liu, Yangyang Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Exploring the therapeutic potential of silymarin-based herbal remedy (prebiotic) and probiotic blend in a mouse model of NAFLD: Insights into gut microbiota modulation and liver health
Tanya Ralli, Shahnawaz Ahmad, Zoya Saifi, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33505-e33505
Open Access | Times Cited: 1
Sodium Butyrate Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line
Bruk Getachew, Antonei B. Csòka, Allison R. Garden, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 2186-2193
Open Access | Times Cited: 11
Dihydromyricetin Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line: Role of GABAA Receptor
Bruk Getachew, Antonei B. Csòka, Yousef Tizabi
Neurotoxicity Research (2022) Vol. 40, Iss. 3, pp. 892-899
Closed Access | Times Cited: 4
The Function of Tryptophan Metabolism in the Gut
Xiongzhuo Tang, Li Wan, Jing Gao, et al.
(2024), pp. 17-110
Closed Access
In-silico, in-vitro and ex-vivo evidence of combining silymarin phytopharmaceutical with piperine, and fulvic acid for enhancing its solubility and permeability
Tanya Ralli, Zoya Saifi, Amita Kumari, et al.
Pharmaceutical Development and Technology (2023) Vol. 28, Iss. 7, pp. 595-610
Closed Access | Times Cited: 1
Page 1

Scroll to top